Haffty B G, Choi D H, Goyal S, Silber A, Ranieri K, Matloff E, Lee M H, Nissenblatt M, Toppmeyer D, Moran M S
Department of Radiation Oncology, UMDNJ-RWJMS and Cancer Institute of New Jersey, New Brunswick, NJ 08901, USA.
Ann Oncol. 2009 Oct;20(10):1653-9. doi: 10.1093/annonc/mdp051. Epub 2009 Jun 2.
BACKGROUND: Despite significant differences in age of onset and incidence of breast cancer between Caucasian (CA), African-American (AA) and Korean (KO) women, little is known about differences in BRCA1/2 mutations in these populations. The purpose of this study is to evaluate the prevalence of BRCA1/2 mutations and the association between BRCA1/2 mutation status and secondary malignancies among young women with breast cancer in these three racially diverse groups. METHODS: Patients presenting to our breast cancer follow-up clinics selected solely on having a known breast cancer diagnosis at a young age (YBC defined as age <45 years at diagnosis) were invited to participate in this study. A total of 333 eligible women, 166 CA, 66 AA and 101 KO underwent complete sequencing of BRCA1/2 genes. Family history (FH) was classified as negative, moderate or strong. BRCA1/2 status was classified as wild type (WT), variant of uncertain significance (VUS) or deleterious (DEL). RESULTS: DEL across these three racially diverse populations of YBC were nearly identical: CA 17%, AA 14% and KO 14%. The type of DEL differed with AA having more frequent mutations in BRCA2, compared with CA and KO. VUS were predominantly in BRCA2 and AA had markedly higher frequency of VUS (38%) compared with CA (10%) and KO (12%). At 10-year follow-up from the time of initial diagnosis of breast cancer, the risk of secondary malignancies was similar among WT (14%) and VUS (16%), but markedly higher among DEL (39%). CONCLUSIONS: In these YBC, the frequency of DEL in BRCA1/2 is remarkably similar among the racially diverse groups at 14%-17%. VUS is more common in AA, but aligns closely with WT in risk of second cancers, age of onset and FH.
背景:尽管白种人(CA)、非裔美国人(AA)和韩国人(KO)女性在乳腺癌发病年龄和发病率上存在显著差异,但对于这些人群中BRCA1/2基因突变的差异却知之甚少。本研究的目的是评估这三个种族不同的年轻乳腺癌女性群体中BRCA1/2基因突变的患病率,以及BRCA1/2突变状态与继发性恶性肿瘤之间的关联。 方法:仅选择在我们乳腺癌随访诊所就诊且确诊为年轻乳腺癌(YBC定义为诊断时年龄<45岁)的患者参与本研究。共有333名符合条件的女性,其中166名CA、66名AA和101名KO接受了BRCA1/2基因的全序列检测。家族史(FH)分为阴性、中度或强阳性。BRCA1/2状态分为野生型(WT)、意义未明的变异(VUS)或有害(DEL)。 结果:这三个种族不同的年轻乳腺癌人群中DEL的比例几乎相同:CA为17%,AA为14%,KO为14%。DEL的类型有所不同,与CA和KO相比,AA的BRCA2突变更为频繁。VUS主要存在于BRCA2中,与CA(10%)和KO(12%)相比,AA的VUS频率明显更高(38%)。从乳腺癌初次诊断开始随访10年时,WT(14%)和VUS(16%)发生继发性恶性肿瘤的风险相似,但DEL(39%)明显更高。 结论:在这些年轻乳腺癌患者中,不同种族群体的BRCA1/2基因DEL频率非常相似,为14%-17%。VUS在AA中更为常见,但在继发性癌症风险、发病年龄和家族史上与WT密切相关。
Prostate Cancer Prostatic Dis. 2018-12-12
Breast Cancer Res Treat. 2016-8
BMC Cancer. 2018-2-6
Breast Cancer Res Treat. 2020-2-18
Fertil Steril. 2025-3
Curr Breast Cancer Rep. 2024-3
Breast Cancer Res. 2023-2-10